SCHEMBL2372122

SCHEMBL2372122

Cc1cc(S(=O)(=O)NC2CC2)ccc1Br

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.65
▸ SMN1; SMN2 Q16637 2/20 0.56
▸ POLB P06746 1/20 0.56
▸ GAA P10253 1/20 0.56
▸ TDP1 Q9NUW8 2/20 0.55
▸ KMT2A Q03164 2/20 0.55
▸ KDM4E B2RXH2 2/20 0.51
▸ RECQL P46063 1/20 0.51
▸ CYP3A4 P08684 1/20 0.51
▸ TSHR P16473 1/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ HTT P42858 1/20 0.51
▸ PARG Q86W56 1/20 0.51
▸ LMNA P02545 1/20 0.49
▸ PDE4A P27815 1/20 0.49
▸ PDE4B Q07343 1/20 0.49
▸ PDE4C Q08493 1/20 0.49
▸ PDE4D Q08499 1/20 0.49
▸ MEN1 O00255 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL848293 0.93 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2POLBGAATDP1
SCHEMBL29498481 0.93 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2POLBGAATDP1
SCHEMBL1727236 0.93 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2POLBGAATDP1
SCHEMBL19994841 0.92 ALDH1A1 (0.73) ALDH1A1SMN1; SMN2POLBGAATDP1
SCHEMBL19989503 0.90 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2POLBGAATDP1
SCHEMBL29859380 0.90 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2POLBGAATDP1
SCHEMBL29859453 0.89 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2POLBGAATDP1
SCHEMBL19989477 0.89 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2POLBGAATDP1
SCHEMBL19989476 0.89 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2POLBGAATDP1
SCHEMBL19989269 0.87 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2POLBGAATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2547204-A2 ARYL AND HETARYL SULFONAMIDES AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS Bayer Intellectual Property GmbH (DE) 2013-01-23 — — EP claimed
US-20110230350-A1 ARYL-AND HETARYLSULFONAMIDES AS ACTIVE INGREDIENTS AGAINST ABIOTIC PLANT STRESS BAYER CROPSCIENCE AG (DE) 2011-09-22 — — US claimed
WO-2011113861-A2 ARYL AND HETARYL SULFONAMIDES AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS BAYER CROPSCIENCE AG (DE) 2011-09-22 — — WO claimed
US-20110230350-A1 ARYL-AND HETARYLSULFONAMIDES AS ACTIVE INGREDIENTS AGAINST ABIOTIC PLANT STRESS BAYER CROPSCIENCE AG (DE) 2011-09-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230350-A1 ARYL-AND HETARYLSULFONAMIDES AS ACTIVE INGREDIENTS AGAINST ABIOTIC PLANT STRESS STS, ARSA, TST ALDH1A1 1980/4885SMN1; SMN2 4603/4885POLB 3490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback